Beijing DNAK^® Biological Technology Co., Ltd was formed in 2015 after acquiring a number of PCR patents from Peking University. The mission of DNAK^® is to market and promote the newest gene research innovations,  provide hospitals and other medical providers with the most efficient diagnosis and treatment method. The company's vision is to become a industry leader in personalized gene detection, auxiliary clinical diagnosis, and new drug development.